The abstract is read at the publisher; the summary is JClub's.
High Calb protein expression is linked to shorter progression-free survival in meningioma patients, with Calb detected in ~30% of primary tumors.
- Why it matters: Molecular profiling improves risk stratification, but the clinical meaning of transcriptional changes like CALB1 upregulation is still unclear.
- What they did: The study assessed Calb immunoreactivity in 231 tissue microarray cores from 147 patients and CALB1 transcript, methylation, and copy-number in a separate cohort of 110 primary meningiomas.
- The result: High Calb protein expression predicts worse PFS after clinical adjustment and remains seen in WHO grade 2; CALB1 transcript levels associate with 6q loss and CALB1 hypo-methylation, while Calretinin and PR do not.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.